← Evidence map

ArticleHaematologica2022

How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?

Ashley Pinchinat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35112555